A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract Meeting Abstract

  

Authors:	Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Sandhu, K. S.; Barker, J. N.; Shia, J.; Yan, X; Daley, W. L.; Moore, G.; Fatmi, S.; Soto, C.; Gomes, A.; Slingerland, J.; Giardina, P.; Peled, J. U.; van den Brink, M. R. M.; Hanash, A. M.
Abstract Title:	A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract
Meeting Title:	Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	26
Issue:	3 Suppl.
Meeting Dates:	2020 Feb 19-23
Meeting Location:	Orlando, FL
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2020-03-01
Start Page:	S51
End Page:	S52
Language:	English
ACCESSION:	WOS:000516887900069
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2019.12.124
Notes:	Meeting Abstract: 68 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/164043